Key Points Pfizer will buy Metsera for at least $47.50 per share. Pfizer could end up paying closer to$70 per share. Pfizer wants to sell GLP-1 weight loss drugs, and Metsera has four such candidates. 10 stocks we like better than Pfizer › Pfizer (NYSE: PFE), the one-time COVID vaccine hero turned Ozempic craze zero, is marching higher Monday after announcing it will try to recover from its danuglipron setback by buying another drug company with weight loss dreams. As of 12:25 p.m. ET, Pfizer st ...